{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T20:10:04Z","timestamp":1648930204483},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Therapies"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.2515\/therapie\/2009053","type":"journal-article","created":{"date-parts":[[2009,10,29]],"date-time":"2009-10-29T10:49:42Z","timestamp":1256813382000},"page":"325-330","source":"Crossref","is-referenced-by-count":0,"title":["\u00c9tude de la toxicocin\u00e9tique de l\u2019hexobarbital apr\u00e8s intoxication aigu\u00eb polym\u00e9dicamenteuse"],"prefix":"10.1016","volume":"64","author":[{"given":"Emmanuelle","family":"Guillot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emuri","family":"Abe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9milie","family":"Gautier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Djillali","family":"Annane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Claude","family":"Alvarez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.2515\/therapie\/2009053_bb0005","first-page":"596","article-title":"Evipan: a preliminary report on a new intravenous anaesthesic","volume":"29","author":"Miller","year":"1933","journal-title":"CMAJ"},{"key":"10.2515\/therapie\/2009053_bb0010","series-title":"Pharmacologie clinique : bases de la th\u00e9rapeutique","first-page":"1945","article-title":"Barbituriques","author":"Viars","year":"1979"},{"key":"10.2515\/therapie\/2009053_bb0015","series-title":"Pharmacologie clinique : bases de la th\u00e9rapeutique","first-page":"1591","article-title":"Hypnotiques","author":"Warot","year":"1979"},{"key":"10.2515\/therapie\/2009053_bb0020","series-title":"Toxicologie clinique et analytique","author":"Frejaville","year":"1971"},{"key":"10.2515\/therapie\/2009053_bb0025","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0379-0738(02)00420-6","article-title":"Suicide by injection of a veterinarian barbiturate enthanasia agent: report of a case ant toxicological analysis","volume":"131","author":"Romain","year":"2003","journal-title":"Forensic Sci Int"},{"key":"10.2515\/therapie\/2009053_bb0030","first-page":"269","article-title":"Intoxication aigu\u00eb par le pentobarbital","volume":"30","author":"R\u00e9si\u00e8re","year":"2001","journal-title":"Presse Med"},{"key":"10.2515\/therapie\/2009053_bb0035","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1051\/ata\/2004016","article-title":"Strat\u00e9gie de validation de m\u00e9thodes de dosage en bioanalyse en vue d\u2019\u00e9tudes pharmacocin\u00e9tiques et toxicologiques","volume":"XVI","author":"Nicolas","year":"2004","journal-title":"Ann Tox Anal"},{"key":"10.2515\/therapie\/2009053_bb0040","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/S0379-0738(01)00483-2","article-title":"Drug and chemical blood-level data 2001","volume":"122","author":"Winek","year":"2001","journal-title":"Forensic Sci Int"},{"key":"10.2515\/therapie\/2009053_bb0045","series-title":"Clarke\u2019s analysis of drugs and poisons","first-page":"1100","article-title":"Hexobarbital","author":"Moffat","year":"2000"},{"key":"10.2515\/therapie\/2009053_bb0050","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/j.1365-2125.1983.tb01530.x","article-title":"Disposition of hexobarbitone in healthy man: kinetics of parent drug and metabolites following oral administration","volume":"15","author":"Vermeulen","year":"1983","journal-title":"Br J Clin Pharmacol"},{"key":"10.2515\/therapie\/2009053_bb0055","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1002\/bdd.2510070307","article-title":"Pharmacokinetics of orally administered hexobarbital in plasma and subject of healthy subject","volume":"7","author":"Van der Graaff","year":"1986","journal-title":"Biopharm Drug Dispos"},{"key":"10.2515\/therapie\/2009053_bb0060","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1007\/BF00607575","article-title":"Kinetics of hexobarbital and dipyrone in critical care patients receiving high-dose pentobarbital","volume":"32","author":"Heinemeyer","year":"1987","journal-title":"Eur J Clin Pharmacol"},{"key":"10.2515\/therapie\/2009053_bb0065","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3109\/00498259309059419","article-title":"Hexobarbital metabolism: a new metabolic pathway to produce 1,5-dimethylbarbituric acid and cyclohexenone-glutathione adduct via 3\u2019-oxohexobarbital","volume":"23","author":"Takenoshita","year":"1993","journal-title":"Xenobiotica"},{"key":"10.2515\/therapie\/2009053_bb0070","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1248\/bpb.28.1711","article-title":"Contribution of human hepatic cytochrome P450 isoforms to the metabolism of psychotropic drugs","volume":"28","author":"Niwa","year":"2005","journal-title":"Biol Pharm Bull"},{"key":"10.2515\/therapie\/2009053_bb0075","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2125.1994.tb04336.x","article-title":"Diazepam metabolism by human liver microsomes is mediated by both S-mephenytoin hydroxylase and CYP3A isoforms","volume":"38","author":"Andersson","year":"1994","journal-title":"Br J Clin Pharmac"},{"key":"10.2515\/therapie\/2009053_bb0080","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1016\/j.clpt.2005.08.020","article-title":"CYP2C19 genotype affects diazepam pharmacokinetics and emergence from general anesthesia","volume":"78","author":"Inomata","year":"2005","journal-title":"Clin Pharmacol Ther"},{"key":"10.2515\/therapie\/2009053_bb0085","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1046\/j.1365-2710.2000.00281.x","article-title":"Pharmacogenetics and psychopharmacotherapy","volume":"25","author":"Poolsup","year":"2000","journal-title":"J Clin Pharm Ther"},{"key":"10.2515\/therapie\/2009053_bb0090","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1111\/j.1365-2710.2007.00829.x","article-title":"Effects of genetic polymorphism of cytochrome P450 enzymes on the pharmacokinetics of benzodiazepines","volume":"32","author":"Fukasawa","year":"2007","journal-title":"J Clin Pharm Ther"},{"key":"10.2515\/therapie\/2009053_bb0095","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00008571-199512000-00001","article-title":"The pharmacogenetics of codeine hypoalgesia","volume":"5","author":"Sindrup","year":"1995","journal-title":"Pharmacogenetics"}],"container-title":["Therapies"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0040595716306369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,3]],"date-time":"2019-04-03T07:33:43Z","timestamp":1554276823000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0040595716306369"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0040595716306369"],"URL":"https:\/\/doi.org\/10.2515\/therapie\/2009053","relation":{},"ISSN":["0040-5957"],"issn-type":[{"value":"0040-5957","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]}}}